Subscribe * indicates required Email Address *First Name Last Name /* real people should not fill this in and expect good things – do not remove this or risk form bot signups */ View Past Issues BiotechReality Shots - 11/03/202611 March 2026 BiotechReality Shots15 February 2026 BiotechReality Shots8 February 2026 BiotechReality Shots - 18/01/202618 January 2026 BiotechReality’s 2025 Review and 2026 Predictions27 December 2025 BiotechReality Shots12 December 2025 BiotechReality Shots - 22/11/202522 November 2025
News Clinical Data Oncology Regulatory GSK Secures Japan Orphan Drug Designation for Risvutatug Rezetecan in Small-Cell Lung Cancer 23 March 202623 March 2026 Clinical Trials & Data Desk
Clinical Trials Healthcare & Pharmaceuticals News Pfizer’s Talzenna + Xtandi Delivers Proven rPFS Breakthrough in HRR-Mutated mCSPC 20 March 202620 March 2026 Clinical Trials & Data Desk
Clinical Trials Diabetes News Weight-loss Drugs Eli Lilly Declares Powerful 2% A1C Reduction and 17% Weight Loss in Landmark Phase 3 Trial Results of Retatrutide 19 March 202620 March 2026 Editor's Desk
Regulatory Approval Autoimmune Diseases News ICOTYDE FDA Approval: J&J’s First-Line Oral Peptide Breakthrough for Plaque Psoriasis Treatment 18 March 202618 March 2026 Regulatory Intelligence Desk
Clinical Trials Clinical Data News Oncology Atirmociclib Phase 2 Breakthrough: Pfizer Declares Powerful Results for Metastatic Breast Cancer Treatment 18 March 202618 March 2026 Clinical Trials & Data Desk
Clinical Trials Healthcare & Pharmaceuticals News EBGLYSS (lebrikizumab-lbkz) Delivers Remarkable Phase 3 Results for Pediatric Atopic Dermatitis Treatment 16 March 202616 March 2026 Clinical Trials & Data Desk
